Impact of Capillary Leak and Hypoalbuminemia on PK/PD of Anidulafungin and Caspofungin in Critically Ill Patients
Condition:   Critically Ill Patients Intervention:   Other: Sample collection Sponsors:   Universitaire Ziekenhuizen Leuven;   KU Leuven Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 5, 2019 Category: Research Source Type: clinical trials

Trimethoprim/Sulfamethoxazole Combined With Caspofungin as First-line Therapy in PCP
Condition:   Pneumocystis Pneumonia Interventions:   Drug: caspofungin;   Drug: TMP/SMZ(trimethoprim/sulfisoxazole);   Drug: Methylprednisolone Sponsor:   Bin Du Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 7, 2019 Category: Research Source Type: clinical trials

Empiric Therapy of Patients With Persistent Fever and Agranulocytosis Using Caspofungin
Condition:   Fungal Infection Intervention:   Drug: Caspofungin Sponsor:   Cttq Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 28, 2019 Category: Research Source Type: clinical trials

Pharmacokinetics/Pharmacodynamics (PK/PD) of Caspofungin in Intensive Care Unit (ICU) Patients. An Open Observational Study for Antifungal Treatment's Optimization
Conditions:   Critical Illness;   Infection Intervention:   Drug: Caspofungin Sponsor:   Careggi Hospital Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 10, 2019 Category: Research Source Type: clinical trials

Study of Rezafungin Compared to Caspofungin in Subjects With Candidemia and/or Invasive Candidiasis
Conditions:   Candidemia;   Mycoses;   Fungal Infection;   Invasive Candidiases Interventions:   Drug: Rezafungin for Injection;   Drug: Caspofungin;   Drug: Fluconazole;   Drug: intravenous placebo;   Drug: oral placebo Sponsor:   Cidara Therapeutics Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 12, 2018 Category: Research Source Type: clinical trials